Protea Biosciences Group, Inc., a molecular information company, provides novel bioanalytical solutions to the pharmaceutical, agricultural and life science industries. The company has developed a new and fully-automated molecular information technology platform, the Laser Ablation Electrospray Ionization (LAESI), which enables the direct analysis of molecules without the need for sample preparation. Protea maintains its own laboratory facilities where services are provided to its clients, using LAESI and complementary technologies and expertise. For more information, visit the company’s website at www.proteabio.com.